Headline News about Larimar Therapeutics Inc![]() Via Benzinga
![]() ![]() ![]()
Where Larimar Therapeutics Stands With Analysts
May 18, 2023
Via Benzinga
![]()
After One Year Of Regulatory Hold, Larimar's Ataxia Candidate Sees Some Hope
September 14, 2022
Via Benzinga
![]() ![]() ![]() ![]() Via Benzinga
![]() Via Benzinga
![]() ![]() ![]() ![]() Via Benzinga
![]() ![]() ![]() ![]()
Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2022
October 19, 2022
Via Benzinga
![]()
Benzinga's Top Ratings Upgrades, Downgrades For September 19, 2022
September 19, 2022
Via Benzinga
![]()
Important Biotech Catalysts For September 14, 2022 - End Of The Day Summary
September 14, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Via Benzinga
![]()
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
August 11, 2022
Via Benzinga
![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|